✦ LIBER ✦

A comparison of the efficacy and tolerance of pancrelipase and placebo in the treatment of steatorrhea in cystic fibrosis patients with clinical exocrine pancreatic insufficiency

✍ Scribed by Robert C Stern; Jay D Eisenberg; Jeff S Wagener; Richard Ahrens; Michael Rock; Guillermo doPico; David M Orenstein

Book ID: 119389042
Publisher: Nature Publishing Group
Year: 2000
Tongue: English
Weight: 61 KB
Volume: 95
Category: Article
ISSN: 0002-9270
DOI: 10.1016/s0002-9270(00)01036-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

S2059 Efficacy and Safety of Pancrelipas

S2059 Efficacy and Safety of Pancrelipase Delayed-Release Capsules in Patients with Pancreatic Insufficiency Due to Cystic Fibrosis

✍ Trapnell, Bruce; Maguiness, Karen M.; Graff, Gavin R.; Boyd, David; Caras, Steve 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 51 KB

Ultrase MT12 and Ultrase MT20 in the tre

Ultrase MT12 and Ultrase MT20 in the treatment of exocrine pancreatic insufficiency in cystic fibrosis: safety and efficacy

✍ M. W. Konstan; R. C. Stern; J. R. Trout; J. M. Sherman; H. Eigen; J. S. Wagener; 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 72 KB

M1387 Safety and Efficacy of Immediate-R

M1387 Safety and Efficacy of Immediate-Release Pancrelipase, Viokase®16, With Proton Pump Inhibitor Therapy for Correction of Steatorrhea in Patients With Chronic Pancreatitis With Exocrine Pancreatic Insufficiency

✍ Toskes, Phillip P.; Rydzewska, Grazyna; Basque, Jean-René; Ratheau, Valérie; Sha 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 47 KB

Safety and Tolerability of a New Formula

Safety and Tolerability of a New Formulation of Pancrelipase Delayed-Release Capsules (CREON®) in Children Under Seven Years of Age with Exocrine Pancreatic Insufficiency due to Cystic Fibrosis

✍ , Prof. Gavin R. Graff Professor and Chief Pediatric Pulmonology, John McNamara, 📂 Article 📅 2010 🏛 Springer International Publishing AG 🌐 English ⚖ 179 KB

Efficacy and tolerability of a new formu

Efficacy and tolerability of a new formulation of pancrelipase delayed-release capsules in children aged 7 to 11 years with exocrine pancreatic insufficiency and cystic fibrosis: A multicenter, randomized, double-blind, placebo-controlled, two-period crossover, superiority study

✍ Gavin R. Graff; Karen Maguiness; John McNamara; Ronald Morton; David Boyd; Katri 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 307 KB

Diagnostic and therapeutic applications

Diagnostic and therapeutic applications of bentiromide screening test for exocrine pancreatic insufficiency in patients with cystic fibrosis

✍ S. van Hubbard; Robert O. Wolf; Lucille A. Lester; Alan C. Egge 📂 Article 📅 1984 🏛 Springer US 🌐 English ⚖ 810 KB